BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16890572)

  • 1. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
    Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
    Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S
    Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
    Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A
    J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
    Pawelczyk L; Spaczynski RZ; Banaszewska B; Duleba AJ
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):209-13. PubMed ID: 15063962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
    Baillargeon JP; Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Nestler JE
    Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Clin Endocrinol Metab; 2005 Jan; 90(1):60-5. PubMed ID: 15483106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
    Kriplani A; Agarwal N
    J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome.
    Noyan V; Yucel A; Sagsoz N
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):200-5. PubMed ID: 15262356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
    Maciel GA; Soares Júnior JM; Alves da Motta EL; Abi Haidar M; de Lima GR; Baracat EC
    Fertil Steril; 2004 Feb; 81(2):355-60. PubMed ID: 14967373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C; Luna S; Hernández L; Crespo G; Aguayo P; Arteaga-Troncoso G; Parra A
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1360-5. PubMed ID: 15598674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome.
    Spritzer PM; Comim FV; Capp E; D'Avila A
    Horm Metab Res; 2005 Feb; 37(2):94-8. PubMed ID: 15778926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.
    Belli SH; Graffigna MN; Oneto A; Otero P; Schurman L; Levalle OA
    Fertil Steril; 2004 Mar; 81(3):624-9. PubMed ID: 15037412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?
    Wijeyaratne CN; Nirantharakumar K; Balen AH; Barth JH; Sheriff R; Belchetz PE
    Clin Endocrinol (Oxf); 2004 May; 60(5):560-7. PubMed ID: 15104558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.
    Cibula D; Fanta M; Vrbikova J; Stanicka S; Dvorakova K; Hill M; Skrha J; Zivny J; Skrenkova J
    Hum Reprod; 2005 Jan; 20(1):180-4. PubMed ID: 15576394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome.
    Sönmez AS; Yasar L; Savan K; Koç S; Ozcan J; Toklar A; Yazicioğu F; Akgün A; Sut N
    Hum Reprod; 2005 Jan; 20(1):175-9. PubMed ID: 15513975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.
    Vanky E; Salvesen KA; Heimstad R; Fougner KJ; Romundstad P; Carlsen SM
    Hum Reprod; 2004 Aug; 19(8):1734-40. PubMed ID: 15178665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.